Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
2.060
+0.070 (3.52%)
At close: Sep 18, 2025, 4:00 PM EDT
1.979
-0.081 (-3.94%)
After-hours: Sep 18, 2025, 4:02 PM EDT
Traws Pharma Market Cap
Traws Pharma has a market cap or net worth of $14.34 million as of September 18, 2025. Its market cap has increased by 52.91% in one year.
Market Cap
14.34M
Enterprise Value
1.26M
1-Year Change
52.91%
Ranking
Category
Stock Price
$2.06
Market Cap Chart
Since July 25, 2013, Traws Pharma's market cap has decreased from $409.28M to $14.34M, a decrease of -96.50%. That is a compound annual growth rate of -24.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 14.06M | -56.44% |
| Dec 31, 2024 | 32.27M | 106.05% |
| Dec 29, 2023 | 15.66M | 15.90% |
| Dec 30, 2022 | 13.51M | -74.64% |
| Dec 31, 2021 | 53.27M | -38.16% |
| Dec 31, 2020 | 86.15M | 123.22% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |